OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Multifaceted Biology of PCSK9
Nabil G. Seidah, Annik Prat
Endocrine Reviews (2021) Vol. 43, Iss. 3, pp. 558-582
Open Access | Times Cited: 140
Nabil G. Seidah, Annik Prat
Endocrine Reviews (2021) Vol. 43, Iss. 3, pp. 558-582
Open Access | Times Cited: 140
Showing 26-50 of 140 citing articles:
Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathway
Fengyuan Lu, En Li, Yifeng Gao, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Fengyuan Lu, En Li, Yifeng Gao, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Lowering LDL cholesterol by PCSK9 inhibition: a new era of gene silencing, RNA, and alternative therapies
Mitali Paryani, Nikita Gupta, Sanjay K. Jain, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Mitali Paryani, Nikita Gupta, Sanjay K. Jain, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Lipid Profile, PCSK9 , ANGPTL3 and Lipoprotein (a) Levels in Men Diagnosed With Localized High‐Grade Prostate Cancer and Men At‐Risk of Prostate Cancer
Annick Bergeron, Emilie Wong Chong, France‐Hélène Joncas, et al.
Cancer Medicine (2025) Vol. 14, Iss. 3
Open Access
Annick Bergeron, Emilie Wong Chong, France‐Hélène Joncas, et al.
Cancer Medicine (2025) Vol. 14, Iss. 3
Open Access
Prognostic implications of PCSK9 expression in HER2-positive breast cancer
Zongwen Wu, D. Wu, Chengsheng Huang, et al.
ONCOLOGIE (2025)
Closed Access
Zongwen Wu, D. Wu, Chengsheng Huang, et al.
ONCOLOGIE (2025)
Closed Access
A predictive model to assess the risk of developing hyperlipidemia in patients with type 2 diabetes
Rongzhen Ye, Xitong Huang, Hua Yang, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0315781-e0315781
Open Access
Rongzhen Ye, Xitong Huang, Hua Yang, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0315781-e0315781
Open Access
Lipids dysregulation in diseases: core concepts, targets and treatment strategies
Tikam Chand Dakal, Feng Xiao, Chandra Kanta Bhusal, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Tikam Chand Dakal, Feng Xiao, Chandra Kanta Bhusal, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Impact of PCSK9 gene polymorphism on atorvastatin efficacy in Iraqi hyperlipidemic patients
Khalid Mohammed, Mazin H. Ouda, Suzanne Jubair
Gene Reports (2025), pp. 102181-102181
Closed Access
Khalid Mohammed, Mazin H. Ouda, Suzanne Jubair
Gene Reports (2025), pp. 102181-102181
Closed Access
Research Progress of PCSK9 in Clinical Practice
艳丽 胡
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 200-207
Closed Access
艳丽 胡
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 200-207
Closed Access
Immune checkpoint inhibitors and myocardial infarction
Vencel Juhász, Giselle Alexandra Suero-Abreu, Tomas G. Neilan
Journal of Thrombosis and Thrombolysis (2025)
Closed Access
Vencel Juhász, Giselle Alexandra Suero-Abreu, Tomas G. Neilan
Journal of Thrombosis and Thrombolysis (2025)
Closed Access
Atorvastatin enhances LDL receptor-mediated LDL-C uptake and modulates PCSK9 protein expression in pancreatic β-cells
Zhiyan Zhang, Huadong Zheng, Lusha Zhang, et al.
Islets (2025) Vol. 17, Iss. 1
Open Access
Zhiyan Zhang, Huadong Zheng, Lusha Zhang, et al.
Islets (2025) Vol. 17, Iss. 1
Open Access
Oral and Non-Oral Cholesterol-Lowering Drugs with PCSK9 and Other Biomolecules as Targets: Present Status and Future Prospects
Ajoy Basak
Biomolecules (2025) Vol. 15, Iss. 4, pp. 468-468
Open Access
Ajoy Basak
Biomolecules (2025) Vol. 15, Iss. 4, pp. 468-468
Open Access
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development
Yongmei Wu, Wenqian Song, Su Min, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Yongmei Wu, Wenqian Song, Su Min, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Recent Advances in Gene Therapy for Familial Hypercholesterolemia: An Update Review
Qingan Fu, Lijuan Hu, Tianzhou Shen, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6773-6773
Open Access | Times Cited: 21
Qingan Fu, Lijuan Hu, Tianzhou Shen, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6773-6773
Open Access | Times Cited: 21
Blockade of Hepatocyte PCSK9 Ameliorates Hepatic Ischemia-Reperfusion Injury by Promoting Pink1-Parkin–Mediated Mitophagy
Yu Zhang, Ziyi Wang, Chenyang Jia, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 17, Iss. 1, pp. 149-169
Open Access | Times Cited: 12
Yu Zhang, Ziyi Wang, Chenyang Jia, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 17, Iss. 1, pp. 149-169
Open Access | Times Cited: 12
The Lin28b/Wnt5a axis drives pancreas cancer through crosstalk between cancer associated fibroblasts and tumor epithelium
Zhaoqi Shu, Minghe Fan, Bo Tu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Zhaoqi Shu, Minghe Fan, Bo Tu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review
Hina Arsh, FNU Manoj Kumar, FNU Simran, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 2, pp. 899-908
Open Access | Times Cited: 4
Hina Arsh, FNU Manoj Kumar, FNU Simran, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 2, pp. 899-908
Open Access | Times Cited: 4
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Emilie Wong Chong, France‐Hélène Joncas, Nabil G. Seidah, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Emilie Wong Chong, France‐Hélène Joncas, Nabil G. Seidah, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Impact of High-Density Lipoproteins on Sepsis
Bart De Geest, Mudit Mishra
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12965-12965
Open Access | Times Cited: 17
Bart De Geest, Mudit Mishra
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12965-12965
Open Access | Times Cited: 17
SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-to-Cell Fusion via Activation of SREBP-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2
Rachid Essalmani, Ursula Andréo, Alexandra Evagelidis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 360-360
Open Access | Times Cited: 9
Rachid Essalmani, Ursula Andréo, Alexandra Evagelidis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 360-360
Open Access | Times Cited: 9
Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular Carcinoma
Shiji Fang, Liyun Zheng, Gaofeng Shu, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 8811-8826
Closed Access | Times Cited: 3
Shiji Fang, Liyun Zheng, Gaofeng Shu, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 8811-8826
Closed Access | Times Cited: 3
An update on inclisiran for the treatment of elevated LDL cholesterol
Fotios Barkas, Kausik K. Ray
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 349-358
Closed Access | Times Cited: 3
Fotios Barkas, Kausik K. Ray
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 349-358
Closed Access | Times Cited: 3
PCSK9 aggravated carotid artery stenosis in ApoE-/- mice by promoting the expression of tissue factors in endothelial cells via the TLR4/NF-κB pathway
Chao Peng, Jian Li, Yan Chen, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116314-116314
Closed Access | Times Cited: 3
Chao Peng, Jian Li, Yan Chen, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116314-116314
Closed Access | Times Cited: 3
The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy
Chou‐Yi Hsu, Mustafa Nasrat Abdulrahim, Mohammed Ahmed Mustafa, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 3
Chou‐Yi Hsu, Mustafa Nasrat Abdulrahim, Mohammed Ahmed Mustafa, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 3
MRG15 aggravates sepsis-related liver injury by promoting PCSK9 synthesis and secretion
Boyuan Gu, Yu Jiang, Zhiwei Huang, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112898-112898
Open Access | Times Cited: 3
Boyuan Gu, Yu Jiang, Zhiwei Huang, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112898-112898
Open Access | Times Cited: 3
The Emerging Roles of Intracellular PCSK9 and Their Implications in Endoplasmic Reticulum Stress and Metabolic Diseases
Paul Lebeau, Khrystyna Platko, Jae Hyun Byun, et al.
Metabolites (2022) Vol. 12, Iss. 3, pp. 215-215
Open Access | Times Cited: 15
Paul Lebeau, Khrystyna Platko, Jae Hyun Byun, et al.
Metabolites (2022) Vol. 12, Iss. 3, pp. 215-215
Open Access | Times Cited: 15
